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Antimicrobial-resistant pathogenic members of the Enterobacteriaceae are a well-defined global
problem. We hypothesized that one of the main reservoirs of dissemination of antimicrobial
resistance genes in Vietnam is non-pathogenic intestinal flora, and sought to isolate antimicrobial-
resistant organisms from hospitalized patients and non-hospitalized healthy individuals in Ho Chi
Minh City. The results identified substantial faecal carriage of gentamicin-, ceftazidime- and
nalidixic acid-resistant members of the Enterobacteriaceae in both hospitalized patients and non-
hospitalized healthy individuals. A high prevalence of quinolone resistance determinants was
identified, particularly the qnrS gene, in both community- and hospital-associated strains.
Furthermore, the results demonstrated that a combination of quinolone resistance determinants
can confer resistance to nalidixic acid and ciprofloxacin, even in the apparent absence of
additional chromosomal resistance mutations in wild-type strains and laboratory strains with
transferred plasmids. These data suggest that intestinal commensal organisms are a significant
reservoir for the dissemination of plasmid-mediated quinolone resistance in Ho Chi Minh City.
INTRODUCTION
Pathogenic enteric bacteria that exhibit antimicrobial
resistance are a widespread phenomenon and arguably
constitute a global epidemic. Whilst the depth of knowledge
regarding antimicrobial-resistant organisms isolated from
patients with infection or circulating in the hospital
environment is broad, less is known about antimicrobial-
resistant organisms that are disseminated in the community.
Furthermore, little is known about the antimicrobial
resistance patterns of community-acquired organisms that
circulate in developing countries where antimicrobials are
available without prior consultation with a physician.
Quinolones and fluoroquinolones are groups of antimi-
crobial compounds that are commonly used for the
treatment of many bacterial infections. However, multiple
studies have highlighted that, in recent years, resistance to
fluoroquinolones has increased globally, particularly in
members of the Enterobacteriaceae such as Salmonella and
Klebsiella species (Chau et al., 2007; Strahilevitz et al., 2007;
Wang et al., 2008). Quinolones target the DNA gyrase and
topoisomerase IV enzymes of the bacterial cell, thus
preventing DNA replication (Higgins et al., 2003). The
main resistance mechanisms to quinolones are mutations
in the gyrA and parC genes that alter the conformation of
target amino acid residues within the protein (Jacoby,
2005). The more recent discovery and rapid dissemination
of plasmid-mediated quinolone resistance (PMQR) genes
has further highlighted the problem of quinolone and
Abbreviations: ESBL, extended-spectrum b-lactamase; PMQR, plasmid-
mediated quinolone resistance; RAPD, random amplified polymorphic
DNA.
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ing of resistance mechanisms associated with these
antibacterial compounds (Robicsek et al., 2006a).
The first PMQR gene to be described was named qnrA and
encodes a 218 aa pentapeptide repeat protein that is
capable of protecting the DNA gyrase from the activity of
quinolones (Robicsek et al., 2006a; Tran et al., 2005a, b).
Since the discovery of QnrA, two related PMQR proteins
have been described; these proteins are thought to act in a
manner comparable to QnrA, as they share 40 and 59%
amino acid similarity and have been named QnrB and
QnrS, respectively (Hata et al., 2005; Jacoby et al., 2006). In
vitro acquisition of a Qnr determinant through conjugation
confers a 16–125-fold increase in the MIC, depending on
the nature of the donor strain and the quinolone tested
(Robicsek et al., 2006a).
Two additional PMQR determinants have also been
described, which act using two mechanisms distinct from
that of the Qnr proteins. The first is the aac(69)-Ib-cr gene,
which encodes a variant aminoglycoside acetyltransferase
(Melano et al., 2003; Park et al., 2006). This gene harbours
two individual base pair substitutions, which result in the
enzyme being able to acetylate ciprofloxacin and norflox-
acin, reducing the activity of the fluoroquinolone and
therefore increasing the MIC two- to fourfold (Robicsek
et al., 2006b). The second is the qepA gene, which encodes a
major facilitator subfamily quinolone-specific efflux pump
(Perichon et al., 2007). Experimentally, the QepA protein
does not alter the MICs of ampicillin, erythromycin,
kanamycin or tetracycline, but it does decrease suscept-
ibility to norfloxacin, enrofloxacin and ciprofloxacin by up
to 64-fold (Yamane et al., 2007).
All of the Qnr determinants have been identified in clinical
Enterobacteriaceae isolates; the majority of reported strains
are isolates of Salmonella species and Klebsiella pneumoniae
(Cattoir et al., 2007b; Gay et al., 2006; Mendes et al., 2008;
Strahilevitz et al., 2007). The aac(69)-Ib-cr gene has also
been reported in pathogenic bacteria and, like the qnr
genes, has been found worldwide. The qepA gene has been
reported in members of the Enterobacteriaceae in Japan,
China and France (Cattoir et al., 2008b; Ma et al., 2009;
Yamane et al., 2008). In this study, we attempted to
demonstrate the frequency of carriage of antimicrobial-
resistant members of the Enterobacteriaceae in patients and
healthy individuals living in Ho Chi Minh City, Vietnam.
We determined the prevalence of PMQR genes in these
strains and their effect on the MIC in wild-type strains with
and without additional resistance-associated chromosomal
mutations, as well as in laboratory strains transformed with
isolated plasmid DNA.
METHODS
Bacterial isolation and identification. The strains were collected
from two distinct study populations comprising strains obtained
from patients admitted to hospital (hospital strains) and those from
healthy volunteers from the local community (community strains).
Hospital strains were collected from 194 patients who were admitted
to the Tetanus Intensive Care Ward at the Hospital for Tropical
Diseases in Ho Chi Minh City over the periods of May–October 2004
and June–November 2005. Swabs for culture were taken from the
axilla, nose, sputum and anus of all patients on admission and twice
weekly.
The community strains were collected from stool samples from 27
healthy adults and 77 children (5–14 years) living in Ho Chi Minh
City, who participated in a typhoid vaccine study in 2005 and 2006,
and from nasal and rectal swabs from 100 consecutive 1–3-day-old
healthy neonates, born after uncomplicated pregnancies on a general
obstetrics ward in 2006. None of the individuals (including the
mothers of the neonates) had had any known contact with antibiotics
(prescribed or otherwise) for 4 weeks prior to sample collection.
Samples were cultured on MacConkey medium with and without
supplementation of gentamicin (8 mgm l
21), ceftazidime (2 mgm l
21)
or nalidixic acid (16 mgm l
21) (Sigma-Aldrich). All colony morphol-
ogies grown on MacConkey agar supplemented with antibiotics were
Gram stained. All isolates confirmed to be Gram-negative and
oxidase-negative were identified using an API 20E system
(bioMe ´rieux). For hospitalized patients, the first isolate growing on
each of the selective agars, typically ranging from 2 days to 1 week
after admission, was included in the study.
Antimicrobial susceptibility testing. The susceptibility to genta-
micin, amikacin, ceftazidime, piperacillin–tazobactam, imipenem and
nalidixic acid of members of the Enterobacteriaceae growing on
selective MacConkey agars was determined using a disc diffusion
method on Mueller–Hinton agar plates, according to Clinical and
Laboratory Standards Institute (CLSI) guidelines (CLSI, 2007).
Strains that were identified as resistant to ceftazidime were subjected
to further phenotypic tests to confirm extended-spectrum b-
lactamase (ESBL) production, using discs containing only cefotaxime
(30 mg) and ceftazidime (30 mg) and both antimicrobials combined
with clavulanic acid (10 mg), according to CLSI guidelines (CLSI,
2007). MICs were measured using E-test (AB Biodisk).
PCR and DNA sequencing. Genomic DNA was isolated from all
isolated members of the Enterobacteriaceae using a Wizard Genomic
DNA Preparation kit (Promega), and PCR amplification of the gyrA,
parC, qnrA, qnrB, qnrS, qepA and aac(69)-Ib genes was performed
using the primers outlined in Table 1.
PCR amplification was carried out for 35 cycles at 94 uC for 30 s,
55 uC [gyrA, qnrB, parC, qepA and aac(69)-Ib] or 48 uC( qnrA and
qnrS) for 30 s, and 72 uC for 30 s. Amplification was performed using
a DNA Engine Tetrad 2 (Bio-Rad) and BioTaq polymerase (Bioline).
The resulting PCR amplicons were examined by electrophoresis and
UV visualization on 2% agarose gels containing ethidium bromide.
Amplicons produced from all strains specific for the gyrA, parC, qnrS,
qepA and aac(69)-Ib genes were sequenced with the same primers
used for amplification. The forward and reverse strands of all PCR
products were sequenced using BigDye terminators on a CEQ8000
DNA sequencer (Beckman Coulter).
The genetic environment of the qnrS gene was identified by cloning
plasmid digestions in pUC18 and sequencing. DNA sequences were
edited and analysed using Vector NTI software and compared with
other sequences using BLASTN on the NCBI sequence database.
Molecular typing. Strain differentiation was performed to identify
clonally related strains isolated from different individuals. All
hospital strains and all of the qnr- or aac(69)-Ib-cr-positive
community strains were typed by random amplified polymorphic
DNA (RAPD) PCR using three different primers (Table 1) (Schultsz
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month period and all community strains were processed simulta-
neously for each primer, and electrophoresis was performed under
identical conditions on the same day. RAPD patterns were clustered
and interpreted by combining the resulting amplification patterns of
all three primers and analysed using Bionumeric software (Applied
Maths). Two isolates were considered to be clonally related when
they had RAPD patterns that were identical. Isolates of a given
species differing by one or two bands for all three primers combined
were considered to be variants of a given type. This was based on
similarities in patterns of multiple isolates obtained from individual
patients, by visualization and computer-based analysis using
Bionumerics.
Plasmid extraction and manipulation. Plasmid DNA for electro-
transformation was extracted using a Midiprep Plasmid DNA
Extraction kit, following the manufacturer’s recommendations
(Qiagen). Escherichia coli TOP10 cells (Invitrogen) were transformed
with isolated DNA using a Bio-Rad gene pulser, under conditions
recommended by the manufacturer (Invitrogen). Transformants were
selected on Luria–Bertani medium supplemented with 0.012 mg
ciprofloxacin ml
21.
Conjugation was performed at a 1:1 ratio in liquid cultures by static
incubation overnight at 37 uC. E. coli J53 (sodium azide resistant) was
used as the recipient. Transconjugants were selected by plating onto
Luria–Bertani medium supplemented with 0.03 mg ciprofloxacin
ml
21 and 100 mg sodium azide ml
21.
Plasmid DNA for sizing and visualization was extracted using an
alkaline lysis procedure, as described by Kado & Liu (1981). The
resulting plasmid DNA was separated by electrophoresis in 0.7%
agarose gels made with 16 E buffer (Kado & Liu, 1981). Gels
were run at 90 V for 3 h, stained with ethidium bromide and
photographed. E. coli 39R861 containing plasmids of 7, 36, 63
and 147 kbp was used for sizing plasmid extractions on agarose
gels.
RESULTS AND DISCUSSION
Isolation of antimicrobial-resistant commensal
Enterobacteriaceae
A total of 194 hospitalized patients were tested over the
study period. We isolated 70 E. coli strains, 123 K.
pneumoniae strains and 29 other members of the
Enterobacteriaceae, comprising Citrobacter species,
Enterobacter cloacae, Proteus mirabilis, Klebsiella ornithino-
lytica, Pantoea species and a Vibrio fluvialis, resistant to
gentamicin, ceftazidime or nalidixic acid, or a combination
of these antimicrobials, from these patients. On the basis of
RAPD results, we identified 53 unique E. coli strains, 62
unique K. pneumoniae strains and 16 other unique
members of the Enterobacteriaceae.
The community group totalled 204 people and included 27
healthy adults, 77 healthy children and 100 healthy
neonates. On the basis of culture on selective media
containing gentamicin, ceftazidime or nalidixic acid, we
isolated 340 resistant E. coli strains, 45 resistant K.
pneumoniae strains and 28 other resistant members of the
Enterobacteriaceae. Analysis of the RAPD patterns showed
that all strains isolated from the different individuals were
unique (data not shown). However, on the basis of typing
and resistance patterns, we were able to isolate bacteria
displaying a consistent RAPD pattern from consecutive
isolates obtained over up to 14 days in 18 individuals, thus
indicating carriage (data not shown).
We isolated organisms that were resistant to gentamicin,
ceftazidime or nalidixic acid, or a combination of these,
Table 1. Primers used in this study
NA, Not applicable.
Target gene Gene size
(bp)
Primer name Predicted size of
amplicon (bp)
Primer sequence (5§A 3§)
qnrA 657 QnrA-F 627 TCAGCAAGAGGATTTCTCA
QnrA-R GGCAGCACTATTACTCCCA
qnrB 681 QnrBm-F 264 GGMATHGAAATTCGCCACTG
QnrBm-R TTTGCYGYYCGCCAGTCGAA
qnrS 657 QnrS-F 491 ATGGAAACCTACAATCATAC
QnrS-R AAAAACACCTCGACTTAAGT
aac(69)-Ib 519 Aac(69)-Ib-F 482 TTGCGATGCTCTATGAGTGGCTA
Aac(69)-Ib-R CTCGAATGCCTGGCGTGTTT
qepA 986 QepA_F 199 GCAGGTCCAGCAGCGGGTAG
QepA_R CTTCCTGCCCGAGTATCGTG
gyrA 2628 GyrA-F 625 CGACCTTGCGAGAGAAAT
GyrA-R GTTCCATCAGCCCTTCAA
parC (E. coli) 2258 parC_E_F 395 AAACCTGTTCAGCGCCGCATT
parC_E_R GTGGTGCCGTTAAGCAAA
parC (K. pneumoniae) 2258 parC_K_F1 389 CTGAATGCCAGCGCCAAATT
parC_K_R1 TGCGGTGGAATATCGGTCGC
RAPD NA ERIC1 NA ATGTAAGCTCCTGGGGATTCAC
ERIC2 AAGTAAGTGACTGGGGTGAGCG
TT3 GGCGAGGAGCG
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the healthy children, 64% (64/100) of the healthy neonates
and 68% (132/194) of the tetanus patients. Combining the
data for all 544 unique, resistant strains, 42% of organisms
were resistant to ceftazidime, 63% were resistant to
gentamicin and 74% were resistant to nalidixic acid. All
of the organisms that were resistant to ceftazidime were
confirmed to be ESBL producers.
These results showed that the dissemination of resistant
enteric bacteria is rife in the hospital and the community in
Ho Chi Minh City. Antimicrobials are available without
prescription in Vietnam; therefore, it is tempting to suggest
that this is a primary source of selection for resistant
organisms. However, none of the healthy individuals had
had any antimicrobial therapy for at least 4 weeks prior to
sample collection. The use of antimicrobials in the
production of meat and vegetables is another potential
major source of the ongoing selection of resistant
organisms (Stobberingh & van den Bogaard, 2000;
Teuber, 2001). In recent reports, investigators have shown
intestinal colonization with fluoroquinolone-resistant and
ESBL-producing E. coli in healthy schoolchildren in Latin
America and in vegetarians in the USA (Pallecchi et al.,
2007a, b; Sannes et al., 2008). These data suggest exposure
to particular antimicrobials to such an extent as to
maintain resistant organisms in the intestinal flora and/or
transmission of resistant strains from individuals exposed
to these agents followed by persistent carriage.
Amplification of plasmid-mediated quinolone
resistance genes
All strains were subjected to PCR to amplify the individual
qnrA, qnrB, qnrS, qepA and aac(69)-Ib-cr genes. The
majority of strains that generated a PMQR amplicon were
positive for a single PMQR determinant (Table 2).
Variability in PMQR determinant content was observed
for a limited number of strains with identical RAPD
patterns among the hospital strains. Based on a combina-
tion of RAPD pattern and PMQR content of strains, we
identified 55 unique E. coli strains, 66 K. pneumoniae
strains and 18 other members of the Enterobacteriaceae in
this group.
Of the K. pneumoniae hospital strains, 78.8% (52/66)
produced amplicons for the qnrS gene (Table 2). The
overall numbers of PMQR genes identified were lower in
the community strains compared with the hospital strains;
none the less, 9.4% (32/340) of the E. coli community
strains were PCR positive for the qnrS gene. We were able
to detect aac(69)-lb-cr-positive E. coli and K. pneumoniae
from both hospital and community strains, albeit at a
comparatively low frequency (Table 2). Of the 154 strains
containing PMQR determinants, 98 (63.6%) tested ESBL
positive, including 59/112 (52.7%) qnrS-positive strains.
The sequences for all of the amplicons of the qnrS fragment
were indistinguishable and demonstrated 100% sequence
identity with qnrS1 from K. pneumoniae strain 052250
(GenBank accession no. EF683584). The sequences of the
qnrA and qnrB amplicons and the single qepA PCR
amplicon demonstrated 100% identity to qnrA1 and
qnrB1 from K. pneumoniae plasmid pMG252 (GenBank
accession no. DQ831140) and K. pneumoniae plasmid
pMG298 (GenBank accession no. DQ351241) and E. coli
plasmid pHPA (GenBank accession no. AB263754),
respectively.
These results indicated a very high prevalence of qnr genes,
in particular the qnrS gene, in commensal isolates in Ho
Chi Minh City. Recent reports showing qnr genes
originating from waterborne bacteria may explain the
dissemination of qnr genes in commensal bacteria (Cattoir
et al., 2007a, 2008a). Faecal–oral transmission may
facilitate exchange of qnr genes between waterborne and
intestinal bacteria in the human host.
Table 2. Numbers of unique bacterial isolates from the hospital and community groups carrying a fluoroquinolone resistance
determinant
Source of bacterial
isolate
Bacterial species (n) PCR positive strains [n (%)]
qnrA qnrB qnrS aac(6§)-Ib-cr qepA .1 PMQR*
Hospital group E. coli (55) 5 (9.0) 1 (1.8) 5 (9.0) 9 (16.4) 1 (1.8) 2 (3.6)
K. pneumoniae (66) 4 (6.1) 8 (12.1) 52 (78.8) 11 (16.7) 0 (0) 11 (16.7)
OtherD (18) 6 (33.3) 8 (44.4) 6 (33.3) 0 (0) 0 (0) 4 (22.2)
Community group E. coli (340) 2 (0.6) 0 (0) 32 (9.4) 9 (2.6) 0 (0) 1 (0.3)
K. pneumoniae (45) 0 (0) 0 (0) 15 (33.3) 1 (2.2) 0 (0) 1 (2.2)
Otherd (28) 1 (3.6) 2 (7.1) 2 (7.1) 1 (3.6) 0 (0) 1 (3.6)
*PCR positive for more than one PMQR gene inclusive of data in the rest of the table.
DOther bacterial species isolated from patients included three Enterobacter cloacae, three Citrobacter youngae, three Citrobacter freundii, two P.
mirabilis, one Citrobacter species and one Citrobacter koseri.
dOther bacterial species isolated from the community included two Citrobacter species, one Enterobacter cloacae and one Klebsiella terrigena.
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genes on susceptibility to nalidixic acid and
ciprofloxacin
Chromosomal quinolone resistance in E. coli and K.
pneumoniae is determined predominantly by mutations at
codons 83 and 87 in the gyrA gene. The combinatorial
effect of harbouring one or more of the PMQR genes and
the mutations in the gyrA gene on the susceptibility of the
bacteria to nalidixic acid and ciprofloxacin was assessed in
all unique hospital strains and all PMQR-positive com-
munity strains.
In the 55 unique hospital E. coli strains, 10 (18.2%) had a
single mutation at codon 83, none had a single mutation at
codon 87, and 38 (69.1%) had a double mutation in the
gyrA gene. In 42 community E. coli strains, six (14.3%) had
a single mutation at codon 83 (SerALeu or Ala), none had
a single mutation at codon 87 and 13 (31.0%) had a
double mutation (
83SerALeu or Ala;
87AspAAsn).
In the 66 hospital K. pneumoniae strains sequenced, Ser was
mutated to Tyr, Ile and Phe at position 83 in eight (12.1%),
seven(10.6%)andtwo(3.0%)strains,respectively.Ofthe15
communityK.pneumoniaestrains,SerwasmutatedtoTyrat
codon 83 in one strain (6.7%). Asp was mutated to Ala at
codon 87 in five (7.6%) and one (6.7%) hospital and
community K. pneumoniae strains, respectively.
The combinatorial effects of the various PMQR genes and
associated gyrA mutations on the MICs for nalidixic acid
and ciprofloxacin are shown in Table 3 (hospital strains)
and Table 4 (community strains). The biggest MIC
increases associated with a single gene were associated
with qnrS or aac(69)-Ib-cr. We obtained two strains
carrying the qnrS, qnrB and aac(69)-Ib-cr genes with full
resistance to nalidixic acid and ciprofloxacin, in the
absence of known selective mutation in the gyrA gene
(Table 3). The effect of PMQR genes on the resulting MIC
to fluoroquinolones thus appeared to be reliant on the
number and type of PMQR genes carried by the bacteria.
The co-existence of qnrB and qnrS genes on two different
plasmids within a strain has been shown previously. This
combination did not have any additional effect on
resistance to nalidixic acid (Hu et al., 2008), in contrast
to our strains. We hypothesized a combinatorial effect, due
to the proteins working in an independent manner: QnrB
and QnrS protecting DNA gyrase and Aac(69)-Ib-cr
modifying the fluoroquinolone. However, as Aac(69)-Ib-
cr is thought not to modify quinolones such as nalidixic
acid, we cannot currently rule out any possible effects of
other quinolone resistance mechanisms, such as non-
specific efflux pump activity.
None of the PMQR-positive strains with a MIC of ¢8m g
nalidixic acid l
21 or ¢1 mg ciprofloxacin l
21 demon-
strated any mutation at positions 80 and 84 of the parC
gene, which have been shown to decrease the susceptibility
of E. coli and K. pneumoniae to both nalidixic acid and
ciprofloxacin (Brisse & Verhoef, 2001; Vila et al., 1996).
Table 3. Resulting MIC range (mg l
”1)o fE. coli and K. pneumoniae strains isolated from hospitalized patients, associated with a
variety of combinations of PMQR genes and mutations in the gyrA gene
None of the strains contained mutations at codons 80 and 84 of the parC gene. NAL, Nalidixic acid; CIP, ciprofloxacin.
PCR-positive gene Strain (n) Number of mutations in gyrA
01 2
n NAL CIP n NAL CIP n NAL CIP
None E. coli (36) 5 3–6 0.012–0.016 10 .256 0.19–0.38 21 .256 .32
K. pneumoniae (9) 3 4–32 0.06–1 4 .256 6–.32 2 .256 .32
qnrA E. coli (5) 0 0 5 .256 .32
K. pneumoniae (1) 1 8 0.25 0 0
qnrB E. coli (1) 0 0 1 .256 .32
K. pneumoniae (1) 1 12 0.38 0 0
qnrS E. coli (4) 2 24, 32 0.38 2 .256 .32
K. pneumoniae (42) 38* 6–64 0.38–4 3 .256 3–8 1 .256 .32
aac(69)-Ib-cr E. coli (8)D 00 8 .256 .32
qnrA+qnrS K. pneumoniae (2) 2 24, 32 0.75, 1 0 0
qnrB+aac(69)-Ib-cr K. pneumoniae (3) 0 1 .256 .32 2 .256 .32
qnrS+aac(69)-Ib-cr E. coli (1) 0 0 1 .256 .32
K. pneumoniae (3) 2 16, 32 2 1 .256 .32 0
qnrA+qnrS+aac(69)-Ib-cr K. pneumoniae (1) 1 16 3 0 0
qnrB+qnrS+aac(69)-Ib-cr K. pneumoniae (4) 2 .256 .32 0 2 .256 .32
*NAL: MIC50516, MIC90532; CIP: MIC5050.75, MIC9051.5.
DIncluded one qepA positive strain.
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We selected qnrS PCR-positive strains E. coli E66An
(hospital), K. pneumoniae K1HV (community) and K.
pneumoniae K18An (hospital) for further analysis (Table
5). We were unable to transfer nalidixic acid resistance by
conjugation from either of the two K. pneumoniae strains
into the E. coli recipient. However, we were able to
transform E. coli TOP10 with purified plasmid DNA from
both strains and select transformants on the basis of
ciprofloxacin resistance. In contrast, we were able to
transfer nalidixic acid resistance via both conjugation and
transformation from E. coli E66An into another E. coli
strain.
Comparison of the transformants derived from plasmid
DNA isolated from both K. pneumoniae strains and the
transformant and transconjugant derived from E. coli
E66An indicated that sizes and resistance profiles varied
across the different plasmids containing the qnrS gene (as
confirmed by PCR) (Fig. 1, lanes 3, 4, 6 and 7; Table 5).
The transconjugant strain derived from E. coli E66An, but
not the transformants derived from the K. pneumoniae
strains, additionally showed that ESBL production had
been transferred alongside qnrS (Table 5). The correlation
between qnrA or qnrB and ESBL genes is well known
(Iabadene et al., 2008; Jiang et al., 2008; Oktem et al., 2008;
Szabo et al., 2008; Wang et al., 2008), whilst the
relationship between qnrS and other resistance genes is
less well described. ESBL production was observed in only
52.7% of the qnrS-positive strains in our study, and our
transformation and conjugation experiments confirmed
that qnrS genes can be located on plasmids that do not
contain ESBL genes.
Table 4. Resulting MIC range (mg l
”1)o fE. coli and K. pneumoniae strains isolated from healthy individuals, associated with a
variety of combinations of PMQR genes and mutations in the gyrA gene
None of the strains contained mutations at codons 80 and 84 of the parC gene. NAL, Nalidixic acid; CIP, ciprofloxacin.
PCR positive gene Strains (n) Number of mutations in gyrA
01 2
n NAL CIP n NAL CIP n NAL CIP
qnrA E. coli (1) 0 0 1 .256 8
qnrS E. coli (31) 22* 3–64 0.19–1.5 5 .256 1.5–32 4 .256 .32
K. pneumoniae (14) 14D 8–48 0.5–1.5 0 0
aac(69)-Ib-cr E. coli (9) 0 1 .256 2 8 .256 .32
qnrA+qnrS E. coli (1) 1 6 0.5 0 0
qnrS+aac(69)-Ib-cr K. pneumoniae (1) 0 0 1 .256 .32
*NAL: MIC50512, MIC90548; CIP: MIC5050.38, MIC9050.75.
DNAL: MIC50512, MIC90516; CIP: MIC5050.75, MIC9051.5.
Table 5. Resulting susceptibility patterns of wild-type, transconjugant and electrotransformant E. coli and
K. pneumoniae strains
NAL, Nalidixic acid; CIP, ciprofloxacin.
Strain NAL MIC (mg l
”1) CIP MIC (mg l
”1) ESBL* qnrS PCR
E. coli TOP10 1.5 0.006 22
E. coli J53-Azi 4 0.008 22
K. pneumoniae K1HV 8 0.75 2 +
E. coli transformant 1 K1HV 4 0.125 2 +
E. coli transformant 2 K1HV 4 0.125 2 +
K. pneumoniae 18An .256 .32 ++
E. coli transformant 1 E18An 4 0.125 2 +
E. coli transformant 2 E18An 4 0.094 2 +
E. coli E66An .256 .32 ++
E. coli transformant E66An 4 0.125 ++
E. coli transconjugant E66An 16 0.75 ++
*ESBL production was identified by resistance to ceftazidime (2 mg l
21) and confirmed by a double-disc method.
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in this E. coli strain demonstrated 100% sequence identity
to a previously sequenced transposon in plasmid pK245 in
K. pneumoniae strain NK245, from a patient with hospital-
acquired urinary tract infection in Taiwan (Chen et al.,
2006). The qnrS gene appears to ‘piggy back’ on a mobile
element, and selection may occur on the basis of the
presence of other antimicrobial resistance genes (Chen et
al., 2006). This is also suggested by the apparent redundant
nature of the PMQR genes in those strains that have a
double mutation in the gyrA gene. The variability in size of
plasmids harbouring the qnrS gene, observed in our study,
suggests that the genetic element carrying the qnrS gene has
been mobilized onto numerous plasmids of different size.
Our study indicates that commensal organisms may
represent the greatest reservoir and source of dissemination
of plasmid-mediated antimicrobial resistance genes, such
as qnrS, in Vietnam.
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